[Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
There were checked out 32 women in concern with genital bleeding receiving Tamoxifen 20 mg daily for a period of an year. The above mentioned were receiving this medicine because of breast cancer with the help of flexible office hysteroscopy. In the first case in group I--patients with Tamoxifen, was found endometrial pathology in 81.25%. In group II--patients without Tamoxifen was found endometrial pathology in 69%. As a result of this investigation the authors confirm that Tamoxifen increase the risk of endometrial pathology.
Kuzmanov
B
B
D000553:Ambulatory Care; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D004717:Endometrium / Q000187:drug effects / Q000473:pathology*; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014591:Uterine Diseases / Q000139:chemically induced / Q000473:pathology*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen